Helena Colom Codina-rekin lankidetzan egindako argitalpenak (3)

2024

  1. The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

    Pediatric Drugs, Vol. 26, Núm. 3, pp. 331-346

2009

  1. Biopharmaceutic and pharmacodynamic modeling of the in vitro antiproliferative effect of new controlled delivery systems of cisplatin

    European Journal of Pharmaceutical Sciences, Vol. 37, Núm. 3-4, pp. 341-350

  2. Population pharmacokinetics of ganciclovir after intravenous ganciclovir and oral valganciclovir administration in solid organ transplant patients infected with cytomegalovirus

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 11, pp. 4816-4824